Foundation Medicine Nets $25M in Venture Financing

The molecular diagnostics company will use the Series A backing to develop clinical lab tests for use in personalized cancer treatments.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories